Aller au contenu principal
Profil bibliographique

Pier Paolo Avolio

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

145Publications signalées
398Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Prostate Cancer Diagnosis and TreatmentBladder and Urothelial Cancer TreatmentsProstate Cancer Treatment and ResearchRadiomics and Machine Learning in Medical ImagingUrinary and Genital Oncology Studies

Les publications récentes

2026 review OpenAlex

Artificial intelligence for predicting BCG response in non‐muscle‐invasive bladder cancer: a systematic review

Ludovica Cella, Roberto Contieri, Marco Paciotti, Vittorio Fasulo et autres

OBJECTIVES: To systematically identify, appraise and synthesise artificial intelligence (AI) and machine-learning (ML) models that predict treatment response and clinical outcomes after intravesical bacillus Calmette-Guérin (BCG) in non-muscle-invasive bladder cancer (NMIBC), a setting in which current risk calculators underperform, and identifying non-responders …

it, es, nl, fr (code pays fourni par la source)

0 citations British Journal of Urology
Accès ouvert 2026 dataset OpenAlex

Dataset related to article "PSMA-PET/CT for response assessment in localised prostate cancer treated with HIFU: a biopsy-validated study"

Sara Calzolai Lettieri, Alessia Artesani, Priscilla Guglielmo, Sara Damiani et autres

Purpose. High-intensity focused ultrasound (HIFU) is being investigated as a tissue-preserving treatment for localized prostate cancer. Response assessment remains challenging because prostate-specific antigen (PSA) kinetics may not accurately reflect local tumour status. In this study, we evaluated visual and semiquantitative prostate-specific membrane …

it (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 dataset OpenAlex

Dataset related to article "PSMA-PET/CT for response assessment in localised prostate cancer treated with HIFU: a biopsy-validated study"

Sara Calzolai Lettieri, Alessia Artesani, Priscilla Guglielmo, Sara Damiani et autres

Purpose. High-intensity focused ultrasound (HIFU) is being investigated as a tissue-preserving treatment for localized prostate cancer. Response assessment remains challenging because prostate-specific antigen (PSA) kinetics may not accurately reflect local tumour status. In this study, we evaluated visual and semiquantitative prostate-specific membrane …

it (code pays fourni par la source)

0 citations Zenodo (CERN European Organization for Nuclear Research)
Accès ouvert 2026 review OpenAlex

Xpert bladder cancer detection and monitor in urothelial carcinoma: systematic review and meta-analysis

Ludovica Cella, Vittorio Fasulo, Alessandro Uleri, Andrea Piccolini et autres

Xpert Bladder Cancer (BC) is an mRNA-based urine assay for diagnosis and surveillance of urothelial carcinoma. Although previous meta-analyses have examined Xpert, none has evaluated its accuracy in both BC detection and non-muscle-invasive bladder cancer (NMIBC) surveillance, while also exploring its potential …

it, fr (code pays fourni par la source)

0 citations Scientific Reports
Accès ouvert 2026 article OpenAlex

MUSeg‐PSV: A Real‐Time Deep‐Learning Segmentation of the Prostate Gland and Seminal Vesicles on 29‐MHz Micro‐Ultrasound

Ludovica Cella, Marco Paciotti, Giacomo Cavadini, Luca Di Stefano et autres

Abstract Objectives This study aimed to develop and evaluate MUSeg‐PSV, a real‐time deep‐learning framework for segmentation of the prostate gland and seminal vesicles on 29‐MHz micro‐ultrasound (MicroUS), intended to support anatomical orientation during MicroUS‐guided prostate biopsy and local staging of prostate cancer. …

it, us (code pays fourni par la source)

0 citations BJUI Compass
Accès ouvert 2026 article OpenAlex

Neoadjuvant Intravesical Mitomycin C for NMIBC: A Phase III Single-Center, Open-Label Randomized Clinical Trial

Roberto Contieri, Alberto Saita, Marco Paciotti, Alessandro Uleri et autres

Background and Objective: Transurethral resection of bladder tumor (TURBT) is the standard for non-muscle-invasive bladder cancer (NMIBC), yet recurrence rates remain high. This study evaluates the safety, tolerability, and efficacy of neoadjuvant intravesical mitomycin C (neoMMC) before TURBT in reducing recurrence and …

it (code pays fourni par la source)

0 citations Cancers

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.